Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PhenQ
- Development stage
- Unknown
- Lead developer
- Wolfson Brands
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
PhenQ is a multi-ingredient dietary supplement marketed primarily for weight loss and weight management. Developed by Wolfson Brands (UK) Limited, it is formulated to target weight loss through several mechanisms, including fat burning, appetite suppression, and energy enhancement. The product's key proprietary component is **α-Lacys Experience**, a synergistic blend of alpha-lipoic acid and L-cysteine designed to boost metabolism and accelerate thermogenesis. Other active ingredients include **Capsimax Powder** (a thermogenic blend of capsicum, piperine, caffeine, and niacin), chromium picolinate for blood sugar regulation, nopal cactus fiber for appetite control, and L-carnitine fumarate to facilitate the conversion of fat into energy. PhenQ is often positioned as a non-prescription alternative to pharmaceutical weight loss agents like phentermine, although it does not contain phentermine or any controlled substances.
- Brand names
- PhenQ
- Other names
- PhenQ
02
Targets
SLC7A1 (Cationic amino acid transporter 1)ADOR (Adenosine receptors)TRPV1 (Transient receptor potential cation channel subfamily V member 1)INSR (Insulin receptor)
Beyond the preview
Go deeper on PhenQ.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PhenQ.